Rowland & CO Investment Counsel Bio Rad Laboratories, Inc. Transaction History

Rowland & CO Investment Counsel

$486 Million
Q3 2024

A detailed history of Rowland & CO Investment Counsel transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 883 shares of BIO stock, worth $318,657. This represents 0.06% of its overall portfolio holdings.

Number of Shares

883

Previous 978 9.71%

Holding current value

$318,657

Previous $267,000 10.49%

% of portfolio

0.06%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$263.97 - $344.64 $25,077 - $32,740	-95 Reduced 9.71%	883 $295,000
Q2 2024 Jul 29, 2024	SELL	$268.26 - $339.48 $20,119 - $25,461	-75 Reduced 7.12%	978 $267,000
Q1 2024 Apr 08, 2024	SELL	$304.11 - $351.99 $5,473 - $6,335	-18 Reduced 1.68%	1,053 $364,000
Q4 2023 Jan 03, 2024	SELL	$269.37 - $365.04 $5,387 - $7,300	-20 Reduced 1.83%	1,071 $345,000
Q3 2023 Oct 26, 2023	SELL	$350.25 - $422.63 $47,634 - $57,477	-136 Reduced 11.08%	1,091 $391,000
Q2 2023 Aug 04, 2023	SELL	$359.49 - $486.4 $84,480 - $114,304	-235 Reduced 16.07%	1,227 $465,000
Q1 2023 Apr 25, 2023	SELL	$418.69 - $503.0 $106,765 - $128,265	-255 Reduced 14.85%	1,462 $700,000
Q3 2022 Oct 06, 2022	BUY	$412.59 - $563.26 $26,818 - $36,611	65 Added 3.93%	1,717 $716,000
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $34,775 - $44,787	75 Added 4.76%	1,652 $817,000
Q1 2022 Apr 26, 2022	BUY	$524.57 - $735.42 $125,896 - $176,500	240 Added 17.95%	1,577 $888,000
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $477,758 - $535,614	674 Added 101.66%	1,337 $1.01 Million
Q3 2021 Nov 08, 2021	SELL	$657.71 - $825.77 $443,296 - $556,568	-674 Reduced 50.41%	663 $494,000
Q2 2021 Aug 09, 2021	BUY	$576.64 - $649.04 $66,313 - $74,639	115 Added 9.41%	1,337 $861,000
Q1 2021 May 11, 2021	BUY	$547.01 - $662.35 $160,273 - $194,068	293 Added 31.54%	1,222 $697,000
Q4 2020 Feb 11, 2021	BUY	$510.68 - $643.45 $474,421 - $597,765	929 New	929 $541,000
Q3 2020 Nov 12, 2020	SELL	$454.43 - $535.6 $301,287 - $355,102	-663 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$334.87 - $493.06 $222,018 - $326,898	663 New	663 $299,000

Others Institutions Holding BIO

# of Institutions

455

Shares Held

17.7M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Account

Rowland & CO Investment Counsel Bio Rad Laboratories, Inc. Transaction History